Spinal Injectable Market Expected to Reach USD 51.2 Billion by 2033 with a 8.2% of CAGR , Driven by Rising Incidence of Chronic Lower Back Pain
The global spinal injectable market is projected to be valued at US$ 23.3 billion in 2023 and is anticipated to exceed US$ 51.2 billion by [read full press release…]
